Selected research
Industry Growth & Trends
Global Pharmacokinetic Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharmacokinetic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharmacokinetic Testing market include Certara, L.P., Evotec AG, Pacific BioLabs, GVK Biosciences Private Limited, SGS SA, LGC Limited, Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc. and Creative Bioarray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmacokinetic Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmacokinetic Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmacokinetic Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmacokinetic Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmacokinetic Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmacokinetic Testing Market by Company
Certara, L.P.
Evotec AG
Pacific BioLabs
GVK Biosciences Private Limited
SGS SA
LGC Limited
Pharmaceutical Product Development, LLC
Charles River Laboratories International, Inc.
Creative Bioarray
Pharmacokinetic Testing Segment by Type
Oral Dissolution Testing (FDC)
Intravenous Titration Test (IVRT)
Cell Line In-house Testing (ICR)
Pharmacokinetic Testing Segment by Application
Hospital
Clinic
Research Institutions
Pharmacokinetic Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmacokinetic Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Dissolution Testing (FDC)
- Intravenous Titration Test (IVRT)
- Cell Line In-house Testing (ICR)
Applications
- Hospital
- Clinic
- Research Institutions
Companies covered
- Certara, L.P.
- Evotec AG
- Pacific BioLabs
- GVK Biosciences Private Limited
- SGS SA
- LGC Limited
- Pharmaceutical Product Development, LLC
- Charles River Laboratories International, Inc.
- Creative Bioarray
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmacokinetic Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmacokinetic Testing Market Size by Region (2021-2032)
- 1.4.1 Global Pharmacokinetic Testing Market Size by Region (2021-2026)
- 1.4.2 Global Pharmacokinetic Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmacokinetic Testing Market Size (2021-2032)
- 1.5.1 North America Pharmacokinetic Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmacokinetic Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmacokinetic Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmacokinetic Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmacokinetic Testing Market Size Growth Rate (2021-2032)
2 Pharmacokinetic Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Oral Dissolution Testing (FDC)
- 2.1.2 Intravenous Titration Test (IVRT)
- 2.1.3 Cell Line In-house Testing (ICR)
- 2.2 Global Pharmacokinetic Testing Market Size by Type
- 2.2.1 Global Pharmacokinetic Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmacokinetic Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmacokinetic Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmacokinetic Testing Market Size by Regions
- 2.3.1 North America Pharmacokinetic Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmacokinetic Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmacokinetic Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmacokinetic Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmacokinetic Testing Market Size Breakdown by Type (2021-2026)
3 Pharmacokinetic Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Research Institutions
- 3.2 Global Pharmacokinetic Testing Market Size by Application
- 3.2.1 Global Pharmacokinetic Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmacokinetic Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmacokinetic Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmacokinetic Testing Market Size by Regions
- 3.3.1 North America Pharmacokinetic Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmacokinetic Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmacokinetic Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmacokinetic Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmacokinetic Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmacokinetic Testing Industry Trends
- 4.2 Pharmacokinetic Testing Industry Drivers
- 4.3 Pharmacokinetic Testing Industry Opportunities and Challenges
- 4.4 Pharmacokinetic Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmacokinetic Testing Revenue (2021-2026)
- 5.2 Global Pharmacokinetic Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmacokinetic Testing Key Company Headquarters & Area Served
- 5.4 Global Pharmacokinetic Testing Company, Product Type & Application
- 5.5 Global Pharmacokinetic Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmacokinetic Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmacokinetic Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmacokinetic Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Certara, L.P.
- 6.1.1 Certara, L.P. Company Information
- 6.1.2 Certara, L.P. Business Overview
- 6.1.3 Certara, L.P. Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Certara, L.P. Pharmacokinetic Testing Product Portfolio
- 6.1.5 Certara, L.P. Recent Developments
- 6.2 Evotec AG
- 6.2.1 Evotec AG Company Information
- 6.2.2 Evotec AG Business Overview
- 6.2.3 Evotec AG Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Evotec AG Pharmacokinetic Testing Product Portfolio
- 6.2.5 Evotec AG Recent Developments
- 6.3 Pacific BioLabs
- 6.3.1 Pacific BioLabs Company Information
- 6.3.2 Pacific BioLabs Business Overview
- 6.3.3 Pacific BioLabs Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pacific BioLabs Pharmacokinetic Testing Product Portfolio
- 6.3.5 Pacific BioLabs Recent Developments
- 6.4 GVK Biosciences Private Limited
- 6.4.1 GVK Biosciences Private Limited Company Information
- 6.4.2 GVK Biosciences Private Limited Business Overview
- 6.4.3 GVK Biosciences Private Limited Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GVK Biosciences Private Limited Pharmacokinetic Testing Product Portfolio
- 6.4.5 GVK Biosciences Private Limited Recent Developments
- 6.5 SGS SA
- 6.5.1 SGS SA Company Information
- 6.5.2 SGS SA Business Overview
- 6.5.3 SGS SA Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 SGS SA Pharmacokinetic Testing Product Portfolio
- 6.5.5 SGS SA Recent Developments
- 6.6 LGC Limited
- 6.6.1 LGC Limited Company Information
- 6.6.2 LGC Limited Business Overview
- 6.6.3 LGC Limited Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LGC Limited Pharmacokinetic Testing Product Portfolio
- 6.6.5 LGC Limited Recent Developments
- 6.7 Pharmaceutical Product Development, LLC
- 6.7.1 Pharmaceutical Product Development, LLC Company Information
- 6.7.2 Pharmaceutical Product Development, LLC Business Overview
- 6.7.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Portfolio
- 6.7.5 Pharmaceutical Product Development, LLC Recent Developments
- 6.8 Charles River Laboratories International, Inc.
- 6.8.1 Charles River Laboratories International, Inc. Company Information
- 6.8.2 Charles River Laboratories International, Inc. Business Overview
- 6.8.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Portfolio
- 6.8.5 Charles River Laboratories International, Inc. Recent Developments
- 6.9 Creative Bioarray
- 6.9.1 Creative Bioarray Company Information
- 6.9.2 Creative Bioarray Business Overview
- 6.9.3 Creative Bioarray Pharmacokinetic Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Creative Bioarray Pharmacokinetic Testing Product Portfolio
- 6.9.5 Creative Bioarray Recent Developments
7 North America
- 7.1 North America Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmacokinetic Testing Market Size by Country (2021-2026)
- 7.3 North America Pharmacokinetic Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmacokinetic Testing Market Size by Country (2021-2026)
- 8.3 Europe Pharmacokinetic Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmacokinetic Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmacokinetic Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmacokinetic Testing Market Size by Country (2021-2026)
- 10.3 South America Pharmacokinetic Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmacokinetic Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst